Yarrow Bioscience

YARWNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$266.849 M

$28.68 +1.34%

Close of 22 Sept 2026

Revenue

$570.0K

#3525 by revenue

Earnings

-$26.5M

Loss-making

Shares outstanding

2,669,746

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#246Akebia TherapeuticsAKBA$271.6M
#247ProQR TherapeuticsPRQR$268.1M
#248Yarrow BioscienceYARW$266.8M
#249MacrogenicsMGNX$262.4M
#250Entrada TherapeuticsTRDA$261.3M

What if Yarrow Bioscience were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,249,441

Per share 113,300× higher

Bitcoin $1.74T

$187,186.96

Per share 6,527× higher

Nvidia $5.52T

$592,815.24

Per share 20,670× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Yarrow Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.